AMLN Amylin Pharmaceuticals, Inc. (MM)

Amylin Pharmaceuticals to Webcast Year-End Results SAN DIEGO, Feb. 19 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. will webcast its Quarterly Update Conference Call for the fourth quarter of 2003 on Tuesday, February 24, 2004 at 12:00 p.m. Eastern/9:00 a.m. Pacific. The call will be led by Ginger L. Graham, Amylin's President and Chief Executive Officer. The Company will release financial results for the fourth quarter and fiscal year ended December 31, 2003 that morning before the market opens. The call will be webcast live through Amylin's corporate website and a recording will be made available following the close of the call. To access the webcast, please log on to http://www.amylin.com/ approximately fifteen minutes prior to the call to register, download and install any necessary audio software. A recording will be available by phone for 24 hours beginning approximately one hour after the close of the call and can be accessed at 888-286-8010 (domestic) or 617-801-6888 (international), passcode 97052244. Amylin Pharmaceuticals is committed to improving the lives of people with diabetes and other metabolic diseases through the discovery, development, and commercialization of innovative, cost-effective medicines. DATASOURCE: Amylin Pharmaceuticals, Inc. CONTACT: Mark G. Foletta, Vice President Finance and Chief Financial Officer of Amylin Pharmaceuticals, Inc., +1-858-552-2200 Web site: http://www.amylin.com/

Copyright